SCHEMBL22964154

SCHEMBL22964154

Oc1cccc(OCc2ccc3c(c2)OCO3)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 3/20 0.64
MAOB P27338 7/20 0.60
MAOA P21397 5/20 0.60
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
APP P05067 1/20 0.55
CYP3A4 P08684 2/20 0.52
KMT2A Q03164 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HPGD P15428 1/20 0.48
F10 P00742 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11698521 0.84 MAOB (0.71) MAOBMAOANPC1RAB9ACYP3A4
SCHEMBL18614336 0.84 MAOB (0.59) CALM1MAOBMAOANPC1RAB9A
SCHEMBL18614337 0.84 MAOB (0.59) CALM1MAOBMAOANPC1RAB9A
SCHEMBL21477261 0.84 MAOB (0.59) CALM1MAOBMAOANPC1RAB9A
SCHEMBL1387303 0.81 OPRM1 (0.59) MAOBMAOANPC1RAB9ACYP3A4
SCHEMBL30417964 0.81 OPRM1 (0.59) MAOBMAOANPC1RAB9ACYP3A4
SCHEMBL7908999 0.81 MAOB (0.55) MAOBMAOANPC1RAB9AKMT2A
SCHEMBL11559934 0.79 MAOB (0.68) MAOBMAOANPC1RAB9ACYP3A4
SCHEMBL6479296 0.78 ADRB3 (0.53) CALM1L3MBTL1ALDH1A1LMNAMAPT
SCHEMBL7910795 0.78 MAOB (0.57) MAOBMAOANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961231-B2 NTCP inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-03-30 US disclosed
US-20210040072-A1 NTCP Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040072-A1 NTCP Inhibitors HAVCR2, NPC1, HMGCR CALM1 3616/4885MAOB 4651/4885MAOA 4465/4885
US-10961231-B2 NTCP inhibitors HAVCR2, NPC1, HMGCR CALM1 3616/4885MAOB 4651/4885MAOA 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.